A citation-based method for searching scientific literature

David G Gardner, Songcang Chen, Denis J Glenn, Chris L Grigsby. Hypertension 2007
Times Cited: 97







List of co-cited articles
1334 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng,[...]. J Clin Pharmacol 2010
312
22

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
21

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
695
20


Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
16


Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.
John B Kostis, Milton Packer, Henry R Black, Roland Schmieder, David Henry, Elliott Levy. Am J Hypertens 2004
357
12

Impact of obesity on plasma natriuretic peptide levels.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Peter W F Wilson, Ramachandran S Vasan. Circulation 2004
688
11

Natriuretic peptides.
Lori B Daniels, Alan S Maisel. J Am Coll Cardiol 2007
722
11

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.
R M Fryer, J Segreti, P N Banfor, D L Widomski, B J Backes, C W Lin, S J Ballaron, B F Cox, J M Trevillyan, G A Reinhart,[...]. Br J Pharmacol 2008
98
10

Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II.
A M Richards, G A Wittert, I G Crozier, E A Espiner, T G Yandle, H Ikram, C Frampton. J Hypertens 1993
117
10

The role of natriuretic peptides in cardioprotection.
Toshio Nishikimi, Nobuyo Maeda, Hiroaki Matsuoka. Cardiovasc Res 2006
327
9


Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
E G Bevan, J M Connell, J Doyle, H A Carmichael, D L Davies, A R Lorimer, G T McInnes. J Hypertens 1992
127
9

Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity.
Kazutoshi Miyashita, Hiroshi Itoh, Hirokazu Tsujimoto, Naohisa Tamura, Yasutomo Fukunaga, Masakatsu Sone, Kenichi Yamahara, Daisuke Taura, Megumi Inuzuka, Takuhiro Sonoyama,[...]. Diabetes 2009
200
9

Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.
Kazuomi Kario, Ningling Sun, Fu-Tien Chiang, Ouppatham Supasyndh, Sang Hong Baek, Akiko Inubushi-Molessa, Ying Zhang, Hiromi Gotou, Martin Lefkowitz, Jack Zhang. Hypertension 2014
132
9

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.
Marica Bordicchia, Dianxin Liu, Ez-Zoubir Amri, Gerard Ailhaud, Paolo Dessì-Fulgheri, Chaoying Zhang, Nobuyuki Takahashi, Riccardo Sarzani, Sheila Collins. J Clin Invest 2012
575
9

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
John J V McMurray, Stamatis Adamopoulos, Stefan D Anker, Angelo Auricchio, Michael Böhm, Kenneth Dickstein, Volkmar Falk, Gerasimos Filippatos, Cândida Fonseca, Miguel Angel Gomez-Sanchez,[...]. Eur Heart J 2012
8

Natriuretic peptides: a new lipolytic pathway in human adipocytes.
C Sengenès, M Berlan, I De Glisezinski, M Lafontan, J Galitzky. FASEB J 2000
327
8

Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.
Martin Magnusson, Amra Jujic, Bo Hedblad, Gunnar Engström, Margaretha Persson, Joachim Struck, Nils G Morgenthaler, Peter Nilsson, Christopher Newton-Cheh, Thomas J Wang,[...]. J Clin Endocrinol Metab 2012
105
8


Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.
P M Oliver, J E Fox, R Kim, H A Rockman, H S Kim, R L Reddick, K N Pandey, S L Milgram, O Smithies, N Maeda. Proc Natl Acad Sci U S A 1997
458
7

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
Sandeep R Das, Mark H Drazner, Daniel L Dries, Gloria L Vega, Harold G Stanek, Shuaib M Abdullah, Russell M Canham, Anne K Chung, David Leonard, Frank H Wians,[...]. Circulation 2005
287
7


Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension.
Daniel L Dries, Ronald G Victor, J Eduardo Rame, Richard S Cooper, Xiaodong Wu, Xiaofeng Zhu, David Leonard, Su-Inn Ho, Qingyu Wu, Wendy Post,[...]. Circulation 2005
153
7

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
312
7

Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.
Abigail May Khan, Susan Cheng, Martin Magnusson, Martin G Larson, Christopher Newton-Cheh, Elizabeth L McCabe, Andrea D Coviello, Jose C Florez, Caroline S Fox, Daniel Levy,[...]. J Clin Endocrinol Metab 2011
115
7

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
456
7

Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.
Thomas G von Lueder, Bing H Wang, Andrew R Kompa, Li Huang, Randy Webb, Pierre Jordaan, Dan Atar, Henry Krum. Circ Heart Fail 2015
172
7


Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Torbjorn Omland, Philip A Wolf, Ramachandran S Vasan. N Engl J Med 2004
6


Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.
P Dessì-Fulgheri, R Sarzani, P Tamburrini, A Moraca, E Espinosa, G Cola, L Giantomassi, A Rappelli. J Hypertens 1997
160
6

Atrial natriuretic peptide elevation in congestive heart failure in the human.
J C Burnett, P C Kao, D C Hu, D W Heser, D Heublein, J P Granger, T J Opgenorth, G S Reeder. Science 1986
911
6

Vasopeptidase inhibition: a double-edged sword?
Duncan John Campbell. Hypertension 2003
93
6

B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation.
Ann M Kapoun, Faquan Liang, Gilbert O'Young, Deborah L Damm, Diana Quon, R Tyler White, Kimberly Munson, Andrew Lam, George F Schreiner, Andrew A Protter. Circ Res 2004
222
6

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
J L Rouleau, M A Pfeffer, D J Stewart, D Isaac, F Sestier, E K Kerut, C B Porter, G Proulx, C Qian, A J Block. Lancet 2000
318
6

Natriuretic peptides and cGMP signaling control of energy homeostasis.
Cedric Moro, Max Lafontan. Am J Physiol Heart Circ Physiol 2013
79
7

Atrial natriuretic peptide and adiponectin interactions in man.
Andreas L Birkenfeld, Michael Boschmann, Stefan Engeli, Cedric Moro, Ayman M Arafat, Friedrich C Luft, Jens Jordan. PLoS One 2012
59
10

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
Sarah Mangiafico, Lisa C Costello-Boerrigter, Ingrid A Andersen, Alessandro Cataliotti, John C Burnett. Eur Heart J 2013
159
6

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.
Stefan Engeli, Andreas L Birkenfeld, Pierre-Marie Badin, Virginie Bourlier, Katie Louche, Nathalie Viguerie, Claire Thalamas, Emilie Montastier, Dominique Larrouy, Isabelle Harant,[...]. J Clin Invest 2012
121
6


GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.
Minsuk Kim, Mathew J Platt, Tadao Shibasaki, Susan E Quaggin, Peter H Backx, Susumu Seino, Jeremy A Simpson, Daniel J Drucker. Nat Med 2013
300
6

Natriuretic peptides in cardiovascular diseases: current use and perspectives.
Massimo Volpe, Speranza Rubattu, John Burnett. Eur Heart J 2014
157
6

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
6

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Inder S Anand, Junbo Ge, Carolyn S P Lam, Aldo P Maggioni, Felipe Martinez, Milton Packer, Marc A Pfeffer, Burkert Pieske,[...]. N Engl J Med 2019
578
6

Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.
Speranza Rubattu, Giada Bigatti, Anna Evangelista, Chiara Lanzani, Rosita Stanzione, Laura Zagato, Paolo Manunta, Simona Marchitti, Vanessa Venturelli, Giuseppe Bianchi,[...]. J Am Coll Cardiol 2006
108
5

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Takeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, Takeshi Tokudome, Takeshi Horio, Kenji Mori, Kenji Kangawa. J Am Coll Cardiol 2005
129
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.